Skip to content

Vitamin D Supplementation for the Prevention of Acute Respiratory Tract Infections

Vitamin D Supplementation for the Prevention of Acute Respiratory Tract Infections; a Randomized Double-blinded Trial in Young Finnish Men

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00973583
Enrollment
164
Registered
2009-09-09
Start date
2005-05-31
Completion date
2010-12-31
Last updated
2014-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory Tract Infections

Keywords

vitamin D, infection, Vitamin D for the prevention of respiratory tract infections

Brief summary

The investigators earlier clinical study in 754 young Finnish men demonstrated a significant negative association of serum 25-OHD concentration with acute respiratory tract infections. The present study aimed to determine whether vitamin D supplementation may decrease the incidence of acute respiratory tract infections.

Detailed description

Subjects comprised 164 male conscripts at a military base in Finland. Half of the participants were randomly allocated to receive 400 IU vitamin D daily and half received placebo from October through March. Serum vitamin D and plasma parathyroid hormone concentrations were determined. Subjects were followed for 6 months and the primary outcome was the number of days absent from duty due to ARTI.

Interventions

DIETARY_SUPPLEMENTvitamin D

vitamin D3 400 IU daily

DIETARY_SUPPLEMENTplacebo

placebo

Sponsors

Finnish Defense Forces
CollaboratorOTHER_GOV
Tampere University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Healthy volunteers
Yes

Exclusion criteria

* Use vitamin D

Design outcomes

Primary

MeasureTime frame
Number of days absent from duty due to respiratory tract infection6 months

Secondary

MeasureTime frame
The proportion of men remaining healthy throughout the 6-month study period6 months
The number needed to treat calculated from the proportion of men without any days absent from duty6 months

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026